TELA Bio (NASDAQ:TELA) Releases Earnings Results, Beats Expectations By $0.01 EPS

TELA Bio (NASDAQ:TELA) announced its quarterly earnings data on Thursday. The company reported ($0.23) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.01, Zacks reports. TELA Bio had a negative net margin of 60.49% and a negative return on equity of 556.18%. The firm had revenue of $17.65 million during the quarter, compared to analyst estimates of $23.17 million. TELA Bio updated its Q1 2025 guidance to EPS and its FY 2025 guidance to EPS.

TELA Bio Stock Down 37.2 %

Shares of TELA opened at $1.47 on Friday. The stock has a market capitalization of $57.90 million, a PE ratio of -0.87 and a beta of 1.10. TELA Bio has a 1 year low of $1.28 and a 1 year high of $6.50. The company has a debt-to-equity ratio of 14.22, a quick ratio of 1.81 and a current ratio of 2.62. The company’s 50-day simple moving average is $2.56 and its 200-day simple moving average is $2.70.

Analysts Set New Price Targets

TELA has been the topic of a number of recent analyst reports. Canaccord Genuity Group decreased their target price on shares of TELA Bio from $12.00 to $7.00 and set a “buy” rating on the stock in a research report on Friday. Piper Sandler cut shares of TELA Bio from an “overweight” rating to a “neutral” rating and decreased their target price for the company from $5.00 to $2.00 in a research report on Friday.

About TELA Bio

TELA Bio, Inc, a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs.